Timing of drug treatment is crucial [2]

British Medical Journal

Volumn 328, Issue 7432, 2004, Pages 167-

  Knapp, Martin ^a  

^a Mildura Base Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RAMIPRIL; ANTIHYPERTENSIVE AGENT;

BIOLOGICAL RHYTHM; BLOOD PRESSURE; DEATH; DIALYSIS; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG RESPONSE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; METHODOLOGY; PATIENT; PRESCRIPTION; PRIORITY JOURNAL; SLEEP; TIME; CHRONOTHERAPY; HYPERTENSION; NOTE;

ANTIHYPERTENSIVE AGENTS; CHRONOTHERAPY; HUMANS; HYPERTENSION; RAMIPRIL;

EID: 1642463321     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Taylor R. Conundrum of the HOPE study. BMJ 2003;327:681-2. (20 September.)
2. Shaw DB, Knapp M, Davies DH. Changes in the blood pressure of hypertensives during sleep. Lancet 1963;1:797-8.
3. Knapp MS. An audit of pre-dialysis renal failure in a non-metropolitan clinic. Nephrology 2003:8(suppl):A90.
4. Knapp MS. Chronotherapeutics; a new clinical science. BMJ 1978;i:137.
5. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ 2002;324:699.